Adel M. Naylor-Olsen

1.1k citations

23 papers · 598 indexed · h-index 14

Co-authors: Sidney D. Lewis Bobby J. Lucas Joseph J. Lynch Joseph P. Vacca William C. Lumma A. M. Mulichak Thomas J. Tucker Elizabeth A. Lyle
Topics: Chemical Synthesis and Analysis (9 papers)Peptidase Inhibition and Analysis (9 papers)Chemical synthesis and pharmacological studies (6 papers)
Cited by: Hematology Organic Chemistry Immunology and Allergy
Journals: Journal of Medicinal Chemistry European Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: United States China France

In The Last Decade

Adel M. Naylor-Olsen

23 papers receiving 543 citations

Peers

Countries citing papers authored by Adel M. Naylor-Olsen

Since Specialization

Citations

This map shows the geographic impact of Adel M. Naylor-Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel M. Naylor-Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel M. Naylor-Olsen more than expected).

Fields of papers citing papers by Adel M. Naylor-Olsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel M. Naylor-Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel M. Naylor-Olsen. The network helps show where Adel M. Naylor-Olsen may publish in the future.

Co-authorship network of co-authors of Adel M. Naylor-Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Adel M. Naylor-Olsen. A scholar is included among the top collaborators of Adel M. Naylor-Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel M. Naylor-Olsen. Adel M. Naylor-Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile 2017 ·ACS Infectious Diseases ·Jeremy R. Duvall,Leanne L. Bedard,Adel M. Naylor-Olsen,Abigail L. Manson,Joshua A. Bittker,(unknown),Mark E. Fitzgerald,(unknown),Maurice D. Lee,Jean‐Charles Marié,Giovanni Muncipinto,(unknown),Deming Xu,(unknown),(unknown),Ashlee M. Earl,Michelle Palmer,Michael A. Foley,Joseph P. Vacca,Christina Scherer	16
2	Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs,(unknown),(unknown),Swati P. Mercer,Linda S. Payne,Kenneth J. Stauffer,Peter Williams,Jacquelynn J. Cook,Julie A. Krueger,Sidney D. Lewis,Bobby J. Lucas,Elizabeth A. Lyle,Joseph J. Lynch,Daniel R. McMasters,Adel M. Naylor-Olsen,(unknown),Audrey A. Wallace	6
3	Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles 2008 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs,(unknown),(unknown),(unknown),Adel M. Naylor-Olsen,Daniel R. McMasters,Julie A. Krueger,Sidney D. Lewis,Bobby J. Lucas,Lawrence C. Kuo,Youwei Yan,Joseph J. Lynch,(unknown)	9
4	Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: Weakly basic azoles 2005 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs,(unknown),(unknown),(unknown),Adel M. Naylor-Olsen,Julie A. Krueger,Sidney D. Lewis,Bobby J. Lucas	12
5	Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Philip E.J. Sanderson,Matthew G. Stanton,Bruce D. Dorsey,Terry A. Lyle,Colleen M. McDonough,William M. Sanders,(unknown),Adel M. Naylor-Olsen,Julie A. Krueger,Sidney D. Lewis,Bobby J. Lucas,Joseph J. Lynch,Youwei Yan	21
6	Non-Peptide αvβ3 antagonists. Part 6: Design and synthesis of αvβ3 antagonists containing a pyridone or pyrazinone central scaffold 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark E. Duggan,Wasyl Halczenko,Carmen Fernández‐Metzler,C. A. HUNT,Chih‐Tai Leu,(unknown),Adel M. Naylor-Olsen,Thomayant Prueksaritanont,Gary L. Stump,Audrey A. Wallace,Sevgi B. Rodan,John H. Hutchinson	13
7	3-Amino-4-sulfonylpyridinone acetamide and related pyridothiadiazine thrombin inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Philip E.J. Sanderson,(unknown),(unknown),Adel M. Naylor-Olsen,(unknown),(unknown),Franklin C. Clayton,Julie A. Krueger,Sidney D. Lewis,Bobby J. Lucas,Elizabeth A. Lyle,Audrey A. Wallace,(unknown),Youwei Yan	8
8	Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide 2002 ·Bioorganic & Medicinal Chemistry Letters ·Robert Meißner,James J. Perkins,Le T. Duong,George D. Hartman,William F. Hoffman,Joel R. Huff,Nathan C. Ihle,(unknown),Rose Marie Nagy,Adel M. Naylor-Olsen,Gideon A. Rodan,Sevgi B. Rodan,David B. Whitman,Gregg Wesolowski,Mark E. Duggan	38
9	Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·George D. Hartman,Mark E. Duggan,William F. Hoffman,(unknown),James J. Perkins,(unknown),Adel M. Naylor-Olsen,Jacquelynn J. Cook,(unknown),Robert J. Lynch,Guixiang Zhang,Robert J. Gould	4
10	Design of Novel, Potent, Noncovalent Inhibitors of Thrombin with Nonbasic P-1 Substructures: Rapid Structure−Activity Studies by Solid-Phase Synthesis 1998 ·Journal of Medicinal Chemistry ·William C. Lumma,Keith M. Witherup,Thomas J. Tucker,(unknown),John T. Sisko,Adel M. Naylor-Olsen,Sidney D. Lewis,Bobby J. Lucas,Joseph P. Vacca	63
11	L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Philip E.J. Sanderson,(unknown),Bruce D. Dorsey,(unknown),Colleen M. McDonough,Adel M. Naylor-Olsen,I‐Wu Chen,Zhongguo Chen,Jacquelynn J. Cook,(unknown),Julie A. Krueger,Sidney D. Lewis,Jiunn H. Lin,Bobby J. Lucas,Elizabeth A. Lyle,Joseph J. Lynch,Maria T. Stranieri,Kari Vastag,Jules A. Shafer,(unknown)	51
12	Identification and SAR for a selective, nonpeptidyl thrombin inhibitor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Adel M. Naylor-Olsen,G. S. PONTICELLO,Sidney D. Lewis,A. M. Mulichak,(unknown),Charles N. Habecker,Brian T. Phillips,William M. Sanders,Thomas J. Tucker,Jules A. Shafer,Joseph P. Vacca	9
13	C6 Modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption 1998 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs,(unknown),(unknown),Philip E.J. Sanderson,(unknown),Elizabeth Baskin,I‐Wu Chen,(unknown),Jacquelynn J. Cook,(unknown),Sidney D. Lewis,Robert J. Lucas,Elizabeth A. Lyle,Joseph J. Lynch,Adel M. Naylor-Olsen,Maria T. Stranieri,Kari Vastag,(unknown)	19
14	Synthesis, evaluation, and crystallographic analysis of L-371,912: A potent and selective active-site thrombin inhibitor 1997 ·Bioorganic & Medicinal Chemistry Letters ·Terry A. Lyle,Zhongguo Chen,(unknown),Roger Freidinger,Stephen J. Gardell,Sidney D. Lewis,Ying Li,Elizabeth A. Lyle,Joseph J. Lynch,A. M. Mulichak,(unknown),Adel M. Naylor-Olsen,William M. Sanders	34
15	L-373,890, An achiral, noncovalent, subnanomolar thrombin inhibitor 1997 ·Bioorganic & Medicinal Chemistry Letters ·Philip E.J. Sanderson,(unknown),Adel M. Naylor-Olsen,Joseph P. Vacca,(unknown),Sidney D. Lewis,Bobby J. Lucas,Elizabeth A. Lyle,Joseph J. Lynch,A. M. Mulichak	32
16	Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position 1997 ·Journal of Medicinal Chemistry ·Dong-Mei Feng,Stephen J. Gardell,Sidney D. Lewis,Mark G. Bock,Zhongguo Chen,Roger Freidinger,Adel M. Naylor-Olsen,Harri G. Ramjit,Richard Woltmann,Elizabeth Baskin,Joseph J. Lynch,Robert J. Lucas,Jules A. Shafer,(unknown),I‐Wu Chen,Shi‐Shan Mao,Julie A. Krueger,Timothy R. Hare,A. M. Mulichak,Joseph P. Vacca	53
17	Design of Highly Potent Noncovalent Thrombin Inhibitors That Utilize a Novel Lipophilic Binding Pocket in the Thrombin Active Site 1997 ·Journal of Medicinal Chemistry ·Thomas J. Tucker,William C. Lumma,A. M. Mulichak,Zhongguo Chen,Adel M. Naylor-Olsen,Sidney D. Lewis,Robert Lucas,Roger Freidinger,Lawrence C. Kuo	57
18	ChemInform Abstract: Synthesis, Evaluation, and Crystallographic Analysis of L‐371,912: A Potent and Selective Active‐Site Thrombin Inhibitor. 1997 ·ChemInform ·Terry A. Lyle,(unknown),S Appleby,Roger Freidinger,(unknown),Sidney D. Lewis,(unknown),(unknown),Joseph J. Lynch,A. M. Mulichak,(unknown),Adel M. Naylor-Olsen,William M. Sanders	1
19	ChemInform Abstract: Non‐Peptide Fibrinogen Receptor Antagonists. Part 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor Antagonist. 1995 ·ChemInform ·M. E. DUGGAN,Adel M. Naylor-Olsen,James J. Perkins,Paul Anderson,(unknown),Jacquelynn J. Cook,R J Gould,Nathan C. Ihle,George D. Hartman,Joseph J. Lynch,Robert J. Lynch,(unknown),L W Schaffer,Robert L. Smith	1
20	Non-Peptide Fibrinogen Receptor Antagonists. 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor Antagonist 1995 ·Journal of Medicinal Chemistry ·Mark E. Duggan,Adel M. Naylor-Olsen,James J. Perkins,Paul Anderson,(unknown),Jacquelynn J. Cook,Robert J. Gould,Nathan C. Ihle,George D. Hartman	56

About Adel M. Naylor-Olsen

Adel M. Naylor-Olsen is a scholar working on Hematology, Organic Chemistry and Oncology, having authored 23 papers that have together received 598 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), Peptidase Inhibition and Analysis (9 papers) and Chemical synthesis and pharmacological studies (6 papers). The work is most often cited by research in Hematology (193 citations), Organic Chemistry (269 citations) and Immunology and Allergy (53 citations). Adel M. Naylor-Olsen has collaborated with scholars based in United States, China and France. Frequent co-authors include Sidney D. Lewis, Bobby J. Lucas, Joseph J. Lynch, Joseph P. Vacca, William C. Lumma, A. M. Mulichak, Thomas J. Tucker, Elizabeth A. Lyle, Zhongguo Chen and Jacquelynn J. Cook. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact